BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 19, 2019
View Archived Issues
AMP analogues with reduced toxicity
Read More
For whom the pain bell Tolls
Read More
Immune cell stress response may play role in chronic pain
Read More
Phase III portion of the LUME-Meso study does not meet primary endpoint
Read More
CCL5 as novel biomarker associated with poor prognosis in locally advanced pancreatic cancer
Read More
AC Immune initiates phase I study of ACI-3024
Read More
Adaptimmune starts SURPASS study with its next-generation SPEAR T cells targeting MAGE-A4
Read More
Phase I study of Novo Nordisk's NNC-0247-0829 begins
Read More
Phase I plans for NTRX-07, a highly selective and potent CB2 receptor agonist
Read More
Minimal radiation exposure to staff seen with Iomab-B in phase III SIERRA trial
Read More
Phase IIa data for NA-831 in patients with MCI and mild and moderate Alzheimer's disease presented
Read More
Bionomics divulges SCN9A blockers for pain
Read More
Medshine Discovery presents new compounds for tuberculosis
Read More
Sunshine Lake Pharma identifies AOC3 inhibitors
Read More
Adlai Nortye describes IDO1 inhibitors
Read More
New CD73 inhibitors identified by Abbisko Therapeutics
Read More
CTI amends pacritinib study protocol following end of phase IIa meeting with FDA
Read More
Pharmazz cleared in India to initiate phase III study of PMZ-1620 for acute ischemic stroke
Read More
Transgene cleared to begin phase I/IIa study of TG-6002 given by intrahepatic artery infusion
Read More
Spring Bank enters HBV research agreement with NIAID
Read More
Midatech reports data from first-in-human study of MTX-102 in type 1 diabetes
Read More
Imugene to acquire Vaxinia and license to oncolytic virus CF-33
Read More
NDX-1017 safety, pharmacokinetics and pharmacodynamics in healthy subjects reported
Read More
TRAF3 conditional knockout model points to TRAF3 degradation as a target for preventing osteoporosis
Read More
